Enantioselective synthesis of 2-aryl-4-piperidones via rhodium/ phosphoramidite-catalyzed conjugate addition of arylboroxines

Organic Letters

Volumn 7, Issue 12, 2005, Pages 2433-2435

  Jagt, Richard B C ^a   De Vries, Johannes G ^a   Feringa, Ben L ^a   Minnaard, Adriaan J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BORON DERIVATIVE; PHOSPHORAMIDIC ACID DERIVATIVE; PIPERIDONE DERIVATIVE; RHODIUM DERIVATIVE;

ADDITION REACTION; ARTICLE; DRUG CONJUGATION; DRUG ISOLATION; DRUG SYNTHESIS; ENANTIOSELECTIVITY;

EID: 20544440852     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol050734m     Document Type: Article

References (33)

1. For a general review on piperidines, see: Rubiralta, M.; Giralt, E.; Diez, A. Piperidine: Structure, Preparation and Synthetic Applications of Piperidine and its Derivatives; Elsevier: Amsterdam, 1991.
2. For some recent examples of the use of 4-piperidones in the synthesis of biologically active 4-piperidines, see: (a) Tawara, J. N.; Lorenz, P.; Stermitz, F. R. J. Nat. Prod. 1999, 62, 321-323.
3. (b) Watson, P. S.; Jiang, B.; Scott, B. Org. Lett. 2000, 2, 3679-3681.
4. (c) Brooks, C. A.; Comins, D. L. Tetrahedron Lett. 2000, 41, 3551-3553.
5. For an example, see: Mukhtar, T. A.; Wright, G. D. Chem. Rev. 2005, 105, 529-542.
6. (a) For a review of the recent developments in asymmetric routes to substituted piperidines, see: Bailey, P. D.; Millwood, P. A.; Smith, P. D. Chem. Commun. 1998, 633-640.
7. (b) For a review on the recent advances in the synthesis of piperidines and piperidones, see: Weintraub, P. M.; Sabol, J. S.; Kane, J. M.; Borcherding, D. R. Tetrahedron 2003, 59, 2953-2989.
8. For the preparation of N-protected 2,3-dihydropyridones, see: (a) Kozikowski, A. P.; Park, P.-U. J. Org. Chem. 1990, 55, 4668-4682.
9. (b) Comins, D. L.; Chung, G.; Foley, M. A. Heterocycles 1994, 37, 1121-1140.
10. For a review on the asymmetric preparation and synthetic utility of 2,3-dihydro-4-pyridones, see: Comins, D. L. J. Heterocycl. Chem. 1999, 36, 1491-1500.
11. Shintani, R.; Tokunaga, N.; Doi, H.; Hayashi, T. J. Am. Chem. Soc. 2004, 126, 6240-6241.
12. Šebesta, R.; Pizzuti, M. G.; Boersma, A. J.; Minnaard, A. J.; Feringa, B. L. Chem. Commun. 2005, 1711-1713.
13. For related 1,4-additions to 2-piperidones, see: Pineschi, M.; Del Moro, F.; Gini, F.; Minnaard, A. J.; Feringa, B. L. Chem. Commun. 2004, 1244-1245.
14. (a) Van den Berg, M.; Minnaard, A. J.; Schudde, E. P.; Van Esch, J.; de Vries, A. H. M.; de Vries, J. G.; Feringa, B. L. J. Am. Chem. Soc. 2000, 122, 11539-11540.
15. (b) Peña, D.; Minnaard, A. J.; de Vries, J. G.; Feringa, B. L. J. Am. Chem. Soc. 2002, 124, 14552-12553.
16. (c) Van den Berg, M.; Minnaard, A. J.; Haak, R. M.; Leeman, M.; Schudde, E. P.; Meetsma, A.; Feringa, B. L.; de Vries, A. H. M.; Maljaars, C. E. P.; Willans, C. E.; Hyett, D.; Boogers, J. A. F.; Henderickx, H. J. W.; de Vries, J. G. Adv. Synth. Catal. 2003, 345, 308-323.
17. (a) Duursma, A.; Boiteau, J.-G.; Lefort, L.; Boogers, J. A. F.; de Vries, A. H. M.; de Vries, J. G.; Minnaard, A. J.; Feringa, B. L. J. Org. Chem. 2004, 69, 8045-8052.
18. (b) Duursma, A.; Lefort, L.; Boogers, J. A. F.; de Vries, A. H. M.; de Vries, J. G.; Minnaard, A. J.; Feringa, B. L. Org. Biomol. Chem. 2004, 2, 1682-1684.
19. (a) Boiteau, J.-G.; Imbos, R.; Minnaard, A. J.; Feringa, B. L. Org. Lett. 2003, 5, 681-684.
20. See also: Bioteau, J.-G.; Imbos, R.; Minnaard, A. J.; Feringa, B. L. Org. Lett. 2003, 5, 1385.
21. (b) Boiteau, J.-G.; Minnaard, A. J.; Feringa, B. L. J. Org. Chem. 2003, 68, 9481-9484.
22. (c) Duursma, A.; Hoen, R.; Schuppan, J.; Hulst, R.; Minnaard, A. J.; Feringa, B. L. Org. Lett. 2003, 5, 3111-3113.
23. (a) Feringa, B. L. Acc. Chem. Res. 2000, 33, 346-353.
24. (b) Naasz, R.; Arnold, L. A.; Minnaard, A. J.; Feringa, B. L. Angew. Chem., Int. Ed. 2001, 40, 927-930.
25. (c) Arnold, L. A.; Naasz, R.; Minnaard, A. J.; Feringa, B. L. J. Am. Chem. Soc. 2003, 125, 3700-3701.
26. Peña, D.; Lopez, F.; Harutyunyan, A. R.; Minnaard, A. J.; Feringa, B. L. Chem. Commun. 2004, 1836-1837.
27. (a) Sakai, M.; Hayashi, H.; Miyaura, N. Organometallics 1997, 16, 4229-4231.
28. (b) Takaya, Y.; Ogasawara, M.; Hayashi, T.; Sakai, M.; Miyaura, M. J. Am. Chem. Soc. 1998, 120, 5579-5581.
29. (c) For a recent review, see: Hayashi, T.; Yamasaki, K. Chem. Rev. 2003, 103, 2829-2844.
30. Reetz, M. T.; Moulin, D.; Gosberg, A. Org. Lett. 2001, 3, 4083-4085.
31. Kuriyama, M.; Nagai, K.; Yamada, K.; Miwa, Y.; Taga, T.; Tomioka, K. J. Am. Chem. Soc. 2002, 124, 8932-8939.
32. Arylboroxines are obtained by dehydration of arylboronic acids by azeotropic removal of water from their xylene solution or heating at 300 °C in vacuo. For a review, see: Lappert, M. F. Chem. Rev. 1956, 56, 959-1064.
33. Use of arylboroxines was previously reported to have a beneficial effect on both conversion and enantioselectivity in the conjugate addition to highly deactivated 1-alkenylphosphonates; see: Hayashi, T.; Senda, T.; Takaya, Y.; Ogasawara, M. J. Am. Chem. Soc. 1999, 121, 11591-11592.